During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...

The next donor recruitment drives for the Marshall's Match campaign are being held this weekend - with one taking place at ...

The cause of mycosis fungoides is unknown and ... no skin tumors, no lymph nodes or visceral involvement IB: >10% body surface area involved, otherwise same as IB IIA: skin involvement similar ...

In Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable.  Canadians deserve a health care system that provides timely access to quality ...

This process usually takes a few weeks, known as the bridging period, during which additional chemotherapy or radiotherapy is often given to keep the lymphoma stable. Once the CAR T-cell product is ...

including cutaneous t-cell lymphoma (CTCL) subtypes mycosis fungoides (MF) and sezary Syndrome (SS), non-cutaneous t-cell lymphoma (non-CTCL) subtypes angioimmunoblastic t-cell lymphoma (AITL), ...

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.

Qartemi, India’s first international CAR T-cell therapy, is approved for the treatment of adult non-hodgkin lymphoma (NHL). Licensed from Hospital Clínic de Barcelona (HCB), a globally renowned ...

Denileukin diftitox (DAB IL-2) is a relatively novel agent for treating mycosis fungoides, and is FDA approved ... Once bound, the diphtheria toxin enters the cell, inhibits protein synthesis ...

In the study, 69 patients with cutaneous T-cell lymphoma, including the most common subtypes mycosis fungoides and Sézary syndrome, were given DD-cxdl for five consecutive days every 21 days.